FORMELA JEAN FRANCOIS
Insider CIK 1030575 · HZNP Director, 10% owner · EGLT Director, 10% owner · NTLA Director · TBIO Director · SPRO Director · KRRO Director · IKNA Director · ABIO Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRRO Korro Bio, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 6,602 | $14.12 | $93.2K | 132,650 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 31,888 | $14.12 | $450.3K | 640,610 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 6,602 | $14.12 | $93.2K | 132,650 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 31,888 | $14.12 | $450.3K | 640,610 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 8,450 | $13.99 | $118.2K | 672,498 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 1,750 | $13.99 | $24.5K | 139,252 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 1,750 | $13.99 | $24.5K | 139,252 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 8,450 | $13.99 | $118.2K | 672,498 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-26 | 2026-08-28 | 51 | $13.96 | $712 | 141,002 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-26 | 2026-08-28 | 249 | $13.96 | $3.5K | 680,948 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-26 | 2026-08-28 | 51 | $13.96 | $712 | 141,002 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-26 | 2026-08-28 | 249 | $13.96 | $3.5K | 680,948 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-19 | 2026-08-21 | 4,884 | $14.00 | $68.4K | 141,053 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-19 | 2026-08-21 | 23,584 | $14.00 | $330.2K | 681,197 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-19 | 2026-08-21 | 4,884 | $14.00 | $68.4K | 141,053 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-19 | 2026-08-21 | 23,584 | $14.00 | $330.2K | 681,197 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 368 | $13.96 | $5.1K | 145,937 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 1,775 | $13.96 | $24.8K | 704,781 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 368 | $13.96 | $5.1K | 145,937 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-08-11 | 2026-08-13 | 1,775 | $13.96 | $24.8K | 704,781 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-07-06 | 2026-07-07 | 8,506 | $13.96 | $118.7K | 146,305 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-07-06 | 2026-07-07 | 817 | $13.96 | $11.4K | 706,556 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-07-02 | 2026-07-07 | 14,745 | $14.03 | $206.9K | 154,811 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-07-02 | 2026-07-07 | 85,955 | $14.03 | $1.21M | 707,373 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 6,979 | $14.60 | $101.9K | 169,670 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 666 | $14.98 | $10.0K | 793,328 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 114 | $14.98 | $1.7K | 169,556 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 40,679 | $14.60 | $593.9K | 793,994 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 17,426 | $14.25 | $248.3K | 176,649 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 101,579 | $14.25 | $1.45M | 834,673 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 580 | $13.95 | $8.1K | 194,075 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 3,382 | $13.95 | $47.2K | 936,252 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 14,677 | — | $0 | 14,677 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-05-28 | 2026-06-01 | 419 | $13.95 | $5.8K | 194,655 | SEC↗ |
| KRRO Korro Bio, Inc. | S Sale | 2026-05-28 | 2026-06-01 | 2,441 | $13.95 | $34.1K | 939,634 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 6,010 | — | $0 | 6,010 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 5,190 | — | $0 | 5,190 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 17,520 | — | $0 | 17,520 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2024-04-22 | 2024-04-23 | 17,857 | $56.00 | $1000.0K | 195,074 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2023-11-03 | 2023-11-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2023-11-03 | 2023-11-07 | 942,075 | — | $0 | 942,075 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2023-11-03 | 2023-11-07 | 177,217 | — | $0 | 177,217 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2023-06-09 | 2023-06-13 | 17,520 | — | $0 | 17,520 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-06-14 | 2022-06-16 | 7,688 | — | $0 | 7,688 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-06-14 | 2022-06-16 | 5,197 | — | $0 | 7,291 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 13,419 | — | $0 | 13,419 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2021-12-21 | 2021-12-23 | 13,419 | — | $0 | 13,419 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-14 | 2021-12-14 | 5,959 | $14.00 | $83.4K | 1,241,935 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-13 | 2021-12-14 | 8,330 | $14.64 | $122.0K | 1,247,894 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-10 | 2021-12-14 | 11,989 | $15.03 | $180.2K | 1,256,224 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 37,800 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2021-09-14 | 2021-09-14 | 2,055,063 | $38.00 | $78.09M | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 53,823 | $131.82 | $7.09M | 256,537 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 56,188 | $132.77 | $7.46M | 200,349 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 36,519 | $133.77 | $4.89M | 163,830 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 30,831 | $134.86 | $4.16M | 132,999 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 3,033 | $137.01 | $415.6K | 108,073 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 5,400 | $138.05 | $745.5K | 102,673 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 26,019 | $127.02 | $3.30M | 537,357 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 55,525 | $127.79 | $7.10M | 481,832 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 56,280 | $128.77 | $7.25M | 425,552 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 48,724 | $129.88 | $6.33M | 376,828 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 66,468 | $130.79 | $8.69M | 310,360 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 4,201 | $138.58 | $582.2K | 98,472 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 52,320 | $139.96 | $7.32M | 46,152 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 8,027 | $140.80 | $1.13M | 38,125 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 8,420 | $141.66 | $1.19M | 29,705 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 13,556 | $142.88 | $1.94M | 16,149 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 6,149 | $143.45 | $882.1K | 10,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-28 | 2021-06-29 | 21,893 | $135.83 | $2.97M | 111,106 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-06-23 | 2021-06-25 | 3,382 | — | $0 | 3,382 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2021-06-23 | 2021-06-25 | 2,094 | — | $0 | 2,094 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-14 | 2021-06-15 | 93,102 | $87.75 | $8.17M | 577,338 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-14 | 2021-06-15 | 13,309 | $88.70 | $1.18M | 564,029 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-14 | 2021-06-15 | 653 | $89.25 | $58.3K | 563,376 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-14 | 2021-06-15 | 47,422 | $86.73 | $4.11M | 670,440 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-14 | 2021-06-15 | 16,293 | $85.92 | $1.40M | 717,862 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-11 | 2021-06-15 | 29,071 | $85.18 | $2.48M | 736,030 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-06-11 | 2021-06-15 | 1,875 | $85.98 | $161.2K | 734,155 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-29 | 2021-04-30 | 4,513 | $85.43 | $385.5K | 765,101 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-28 | 2021-04-28 | 29,740 | $86.12 | $2.56M | 769,614 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-28 | 2021-04-28 | 102,186 | $85.40 | $8.73M | 799,354 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-27 | 2021-04-28 | 61,680 | $87.08 | $5.37M | 901,540 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-27 | 2021-04-28 | 68,836 | $86.41 | $5.95M | 963,220 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-27 | 2021-04-28 | 79,714 | $85.39 | $6.81M | 1,032,056 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-26 | 2021-04-28 | 806 | $84.93 | $68.5K | 1,111,770 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-05 | 2021-04-07 | 800 | $84.98 | $68.0K | 1,112,576 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-12-14 | 125,000 | $16.00 | $2.00M | 874,634 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 9,499,999 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 11,258,117 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 7,863,094 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 5,362,888 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,099,118 | — | $0 | 1,268,213 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 2,901,609 | — | $0 | 2,901,609 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 749,634 | — | $0 | 749,634 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-26 | 2021-03-01 | 501,945 | $60.29 | $30.26M | 1,113,376 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-12-22 | 2020-12-23 | 79,865 | $25.04 | $2.00M | 46,640 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-12-22 | 2020-12-23 | 2,700 | $25.88 | $69.9K | 43,940 | SEC↗ |
| IKNA Ikena Oncology, Inc. | A Award deriv | 2020-12-21 | 2021-04-01 | 5,362,888 | $1.40 | $7.51M | 5,362,888 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-12-21 | 2020-12-23 | 56,536 | $25.50 | $1.44M | 126,505 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-08-27 | 2020-08-27 | 10,097 | $14.38 | $145.2K | 3,833,122 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-08-26 | 2020-08-27 | 44,381 | $14.80 | $656.8K | 3,843,219 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-08-25 | 2020-08-27 | 34,410 | $15.00 | $516.1K | 3,887,600 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-06-18 | 2020-06-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2020-06-16 | 2020-06-17 | 18,900 | — | $0 | 18,900 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 5,408 | $6.47 | $35.0K | 5,408 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2019-05-21 | 2019-05-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-07-16 | 2018-07-18 | 1,402 | $31.93 | $44.8K | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-07-16 | 2018-07-18 | 5,284 | $30.97 | $163.6K | 1,402 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 2,525,253 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 5,838,230 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-03 | 12,925,244 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | C Conversion | 2018-07-02 | 2018-07-03 | 3,832,010 | — | $0 | 3,922,010 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-06-19 | 2018-06-20 | 5,286 | $27.84 | $147.2K | 1,400 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-06-19 | 2018-06-20 | 1,400 | $28.39 | $39.7K | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 6,073 | — | $0 | 6,073 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-05-17 | 2018-05-21 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-05-16 | 2018-05-17 | 6,686 | $25.04 | $167.4K | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-03-20 | 2018-03-22 | 36,628 | $23.78 | $871.0K | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-03-20 | 2018-03-22 | 2,617 | $25.06 | $65.6K | 36,628 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 982,906 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 1,250,000 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 3,119,633 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 3,662,178 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion deriv | 2017-11-06 | 2017-11-07 | 1,492,645 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 246,272 | — | $0 | 534,658 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 245,605 | — | $0 | 288,386 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 602,589 | — | $0 | 1,979,557 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 328,992 | — | $0 | 863,650 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | C Conversion | 2017-11-06 | 2017-11-07 | 513,318 | — | $0 | 1,376,968 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | P Buy | 2017-11-06 | 2017-11-07 | 428,571 | $14.00 | $6.00M | 2,408,128 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-11 | 2017-07-11 | 80,000 | $16.07 | $1.29M | 3,579,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-10 | 2017-07-11 | 40,000 | $16.17 | $646.8K | 3,659,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-07-07 | 2017-07-11 | 30,000 | $16.77 | $503.1K | 3,699,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2017-05-18 | 2017-05-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-03-10 | 2017-03-13 | 5,504 | $14.06 | $77.4K | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-03-09 | 2017-03-13 | 15,628 | $13.85 | $216.4K | 5,504 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 3,809,524 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 1,333,333 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 761,905 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 946,237 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 2,463,201 | — | $0 | 3,075,028 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 611,827 | — | $0 | 611,827 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 492,640 | — | $0 | 4,429,788 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 862,120 | — | $0 | 3,937,148 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2016-05-05 | 2016-05-09 | 23,529 | — | $0 | 23,529 | SEC↗ |
| EGLT Egalet Corp | C Conversion deriv | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | C Conversion deriv | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | X Exercise deriv | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | C Conversion | 2014-02-11 | 2014-02-12 | 85,620 | $6.00 | $513.7K | 2,110,555 | SEC↗ |
| EGLT Egalet Corp | P Buy | 2014-02-11 | 2014-02-12 | 41,667 | $12.00 | $500.0K | 2,152,222 | SEC↗ |
| EGLT Egalet Corp | C Conversion | 2014-02-11 | 2014-02-12 | 298,083 | $6.00 | $1.79M | 2,024,935 | SEC↗ |
| EGLT Egalet Corp | X Exercise | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 1,726,852 | SEC↗ |
| EGLT Egalet Corp | C Conversion | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 1,696,852 | SEC↗ |
| EGLT Egalet Corp | C Conversion | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 833,098 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2012-10-22 | 2012-10-24 | 238,034 | — | $0 | 313,483 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award | 2012-10-22 | 2012-10-24 | 317,379 | $0.39 | $123.8K | 1,579,542 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | P Buy deriv | 2012-03-02 | 2012-03-06 | 207,110 | $3.62 | $749.7K | 207,110 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | P Buy | 2012-03-02 | 2012-03-06 | 828,443 | $3.62 | $3.00M | 3,688,294 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2012-02-10 | 2012-02-14 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2012-02-10 | 2012-02-14 | 3,500 | — | $0 | 3,500 | SEC↗ |